Cargando…

Cu(3)P/1-MT Nanocomposites Potentiated Photothermal-Immunotherapy

PURPOSE: Photothermal therapy (PTT) is a promising anticancer treatment that involves inducing thermal ablation and enhancing antitumor immune responses. However, it is difficult to completely eradicate tumor foci through thermal ablation alone. Additionally, the PTT elicited antitumor immune respon...

Descripción completa

Detalles Bibliográficos
Autores principales: He, Jiawen, Song, Ruixiang, Xiao, Fengfeng, Wang, Meng, Wen, Liewei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10258043/
https://www.ncbi.nlm.nih.gov/pubmed/37312933
http://dx.doi.org/10.2147/IJN.S414117
_version_ 1785057409559953408
author He, Jiawen
Song, Ruixiang
Xiao, Fengfeng
Wang, Meng
Wen, Liewei
author_facet He, Jiawen
Song, Ruixiang
Xiao, Fengfeng
Wang, Meng
Wen, Liewei
author_sort He, Jiawen
collection PubMed
description PURPOSE: Photothermal therapy (PTT) is a promising anticancer treatment that involves inducing thermal ablation and enhancing antitumor immune responses. However, it is difficult to completely eradicate tumor foci through thermal ablation alone. Additionally, the PTT elicited antitumor immune responses are often insufficient to prevent tumor recurrence or metastasis, due to the presence of an immunosuppressive microenvironment. Therefore, combining photothermal and immunotherapy is believed to be a more effective treatment approach as it can modulate the immune microenvironment and amplify the post-ablation immune response. METHODS: Herein, the indoleamine 2, 3‐dioxygenase‐1 inhibitors (1-MT) loaded copper (I) phosphide nanocomposites (Cu(3)P/1-MT NPs) are prepared for PTT and immunotherapy. The thermal variations of the Cu(3)P/1-MT NPs solution under different conditions were measured. The cellular cytotoxicity and immunogenic cell death (ICD) induction efficiency of Cu(3)P/1-MT NPs were analyzed by cell counting kit-8 assay and flow cytometry in 4T1 cells. And the immune response and antitumor therapeutic efficacy of Cu(3)P/1-MT NPs were evaluated in 4T1-tumor bearing mice. RESULTS: Even at low energy of laser irradiation, Cu(3)P/1-MT NPs remarkably enhanced PTT efficacy and induced immunogenic tumor cell death. Particularly, the tumor-associated antigens (TAAs) could help promote the maturation of dendritic cells (DCs) and antigen presentation, which further activates infiltration of CD8(+) T cells through synergistically inhibiting the indoleamine 2, 3‐dioxygenase‐1. Additionally, Cu(3)P/1-MT NPs decreased the suppressive immune cells such as regulatory T cells (Tregs) and M2 macrophages, indicating an immune suppression modulation effect. CONCLUSION: Cu(3)P/1-MT nanocomposites with excellent photothermal conversion efficiency and immunomodulatory properties were prepared. In addition to enhanced the PTT efficacy and induced immunogenic tumor cell death, it also modulated the immunosuppressive microenvironment. Thereby, this study is expected to offer a practical and convenient approach to amplify the antitumor therapeutic efficiency with photothermal-immunotherapy.
format Online
Article
Text
id pubmed-10258043
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-102580432023-06-13 Cu(3)P/1-MT Nanocomposites Potentiated Photothermal-Immunotherapy He, Jiawen Song, Ruixiang Xiao, Fengfeng Wang, Meng Wen, Liewei Int J Nanomedicine Original Research PURPOSE: Photothermal therapy (PTT) is a promising anticancer treatment that involves inducing thermal ablation and enhancing antitumor immune responses. However, it is difficult to completely eradicate tumor foci through thermal ablation alone. Additionally, the PTT elicited antitumor immune responses are often insufficient to prevent tumor recurrence or metastasis, due to the presence of an immunosuppressive microenvironment. Therefore, combining photothermal and immunotherapy is believed to be a more effective treatment approach as it can modulate the immune microenvironment and amplify the post-ablation immune response. METHODS: Herein, the indoleamine 2, 3‐dioxygenase‐1 inhibitors (1-MT) loaded copper (I) phosphide nanocomposites (Cu(3)P/1-MT NPs) are prepared for PTT and immunotherapy. The thermal variations of the Cu(3)P/1-MT NPs solution under different conditions were measured. The cellular cytotoxicity and immunogenic cell death (ICD) induction efficiency of Cu(3)P/1-MT NPs were analyzed by cell counting kit-8 assay and flow cytometry in 4T1 cells. And the immune response and antitumor therapeutic efficacy of Cu(3)P/1-MT NPs were evaluated in 4T1-tumor bearing mice. RESULTS: Even at low energy of laser irradiation, Cu(3)P/1-MT NPs remarkably enhanced PTT efficacy and induced immunogenic tumor cell death. Particularly, the tumor-associated antigens (TAAs) could help promote the maturation of dendritic cells (DCs) and antigen presentation, which further activates infiltration of CD8(+) T cells through synergistically inhibiting the indoleamine 2, 3‐dioxygenase‐1. Additionally, Cu(3)P/1-MT NPs decreased the suppressive immune cells such as regulatory T cells (Tregs) and M2 macrophages, indicating an immune suppression modulation effect. CONCLUSION: Cu(3)P/1-MT nanocomposites with excellent photothermal conversion efficiency and immunomodulatory properties were prepared. In addition to enhanced the PTT efficacy and induced immunogenic tumor cell death, it also modulated the immunosuppressive microenvironment. Thereby, this study is expected to offer a practical and convenient approach to amplify the antitumor therapeutic efficiency with photothermal-immunotherapy. Dove 2023-06-07 /pmc/articles/PMC10258043/ /pubmed/37312933 http://dx.doi.org/10.2147/IJN.S414117 Text en © 2023 He et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
He, Jiawen
Song, Ruixiang
Xiao, Fengfeng
Wang, Meng
Wen, Liewei
Cu(3)P/1-MT Nanocomposites Potentiated Photothermal-Immunotherapy
title Cu(3)P/1-MT Nanocomposites Potentiated Photothermal-Immunotherapy
title_full Cu(3)P/1-MT Nanocomposites Potentiated Photothermal-Immunotherapy
title_fullStr Cu(3)P/1-MT Nanocomposites Potentiated Photothermal-Immunotherapy
title_full_unstemmed Cu(3)P/1-MT Nanocomposites Potentiated Photothermal-Immunotherapy
title_short Cu(3)P/1-MT Nanocomposites Potentiated Photothermal-Immunotherapy
title_sort cu(3)p/1-mt nanocomposites potentiated photothermal-immunotherapy
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10258043/
https://www.ncbi.nlm.nih.gov/pubmed/37312933
http://dx.doi.org/10.2147/IJN.S414117
work_keys_str_mv AT hejiawen cu3p1mtnanocompositespotentiatedphotothermalimmunotherapy
AT songruixiang cu3p1mtnanocompositespotentiatedphotothermalimmunotherapy
AT xiaofengfeng cu3p1mtnanocompositespotentiatedphotothermalimmunotherapy
AT wangmeng cu3p1mtnanocompositespotentiatedphotothermalimmunotherapy
AT wenliewei cu3p1mtnanocompositespotentiatedphotothermalimmunotherapy